Eaton Erin M, Sealy Linda
Department of Molecular Physiology and Biophysics, Vanderbilt University School of Medicine, Nashville, Tennessee 37232, USA.
J Biol Chem. 2003 Aug 29;278(35):33416-21. doi: 10.1074/jbc.M305680200. Epub 2003 Jun 16.
CCAAT/enhancer-binding protein-beta (C/EBP beta) activator isoforms, C/EBP beta-1 and C/EBP beta-2, differ by only 23 amino acids in the human; however, evidence is accumulating that these transcription factors are functionally distinct. Here we demonstrate that C/EBP beta-1, but not C/EBP beta-2, is conjugated to the small ubiquitin-like modifier (SUMO) family members, SUMO-2 and SUMO-3 despite the fact that the SUMO target consensus is present in both isoforms of this transcription factor. This conjugation is dependent on the integrity of the extreme N terminus of C/EBP beta-1 and requires lysine 173 in the human protein. Furthermore, mutation of this lysine relieves the repression of the cyclin D1 promoter by C/EBP beta-1 without altering the subnuclear localization of C/EBP beta-1. The sumoylation of C/EBP beta-1 is likely to be important in the functional differences observed between C/EBP beta-1 and C/EBP beta-2.
CCAAT/增强子结合蛋白β(C/EBPβ)激活异构体C/EBPβ-1和C/EBPβ-2在人类中仅相差23个氨基酸;然而,越来越多的证据表明这些转录因子在功能上是不同的。在这里,我们证明C/EBPβ-1与小泛素样修饰物(SUMO)家族成员SUMO-2和SUMO-3发生共轭,而C/EBPβ-2则不然,尽管在该转录因子的两种异构体中都存在SUMO靶标共有序列。这种共轭依赖于C/EBPβ-1极端N末端的完整性,并且在人类蛋白质中需要赖氨酸173。此外,该赖氨酸的突变可缓解C/EBPβ-1对细胞周期蛋白D1启动子的抑制作用,而不会改变C/EBPβ-1的核内亚定位。C/EBPβ-1的SUMO化可能在C/EBPβ-1和C/EBPβ-2之间观察到的功能差异中起重要作用。